Drug – bio-affecting and body treating compositions – Topical body preparation containing solid synthetic organic... – Ophthalmic preparation
Patent
1995-02-24
1997-05-20
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Topical body preparation containing solid synthetic organic...
Ophthalmic preparation
514839, 514840, A61K 3174
Patent
active
056310056
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
The present invention relates to the field of ophthalmology. More particularly, the invention is directed to compositions and methods for disinfecting contact lenses, and to the chemical preservation of various types of ophthalmic products.
Contact lenses are exposed to a broad spectrum of microbes during normal wear and become soiled relatively quickly. Routine cleaning and disinfecting of the lenses are therefore required. Although the frequency of cleaning and disinfecting may vary somewhat among different types of lenses and lens care regimens, daily cleaning and disinfecting is normally required. Failure to clean and disinfect the lens properly can lead to a multitude of problems ranging from mere discomfort when the lenses are being worn to serious ocular infections. Ocular infections caused by particularly virulent microbes, such as Pseudomonas aeruginosa, can lead to loss of the infected eye(s) if left untreated or if allowed to reach an advanced stage before treatment is initiated. It is therefore extremely important that patients disinfect their contact lenses in accordance with the, regimen prescribed by their optometrist or ophthalmologist.
Unfortunately, patients frequently fail to follow the prescribed regimens. Many patients find regimens to be difficult to understand and/or complicated, and as a result do not comply with one or more aspects of the regimen. Other patients may have a negative experience with the regimen, such as ocular discomfort attributable to the disinfecting agent, and as a result do not routinely disinfect their lenses or otherwise stray from the prescribed regimen. In either case, the risk of ocular infections is exacerbated.
Despite the availability of various types of contact lens disinfecting systems, such as heat, hydrogen peroxide, and other chemical agents, there continues to be a need for improved systems which: 1) are simple to use, 2) have potent antimicrobial activity, and 3) are nontoxic (i.e., do not cause ocular irritation as the result of binding to the lens material). Moreover, the chemical agents utilized in the currently marketed contact lens disinfection systems generally have limited antifungal activity. Also, many of the chemical agents currently utilized may interact with contact lens materials and/or cause: irritation in some individuals. There is, therefore, a particular need in the fields of contact lens disinfection and ophthalmic composition preservation for safe and effective chemical agents having better antifungal activity. The present invention is directed to satisfaction of the above-cited needs.
SUMMARY OF THE INVENTION
The present invention is directed to methods of using certain amidoamines to disinfect contact lenses and to preserve ophthalmic compositions. The invention is also directed to contact lens disinfecting compositions which contain one or more of the subject compounds, and to various types of ophthalmic compositions (e.g., pharmaceuticals, artificial tears and comfort drops) which contain the compounds for purposes of preserving the compositions against microbial contamination.
In addition to having antimicrobial activity, including both antibacterial and antifungal activity, the compounds of the present invention are also surface active. As a result, the compounds also help to clean contact lenses by facilitating the removal of deposits from the lenses.
The amidoamines of the present invention retain their antimicrobial activity in the presence of Na.sup.+, Ca.sup.++, Cl.sup.- and other inorganic ions produced by the dissociation of alkaline and alkaline earth metal salts (e.g., sodium chloride and calcium chloride), and are compatible with polymers and surfactants frequently used in ophthalmic products, such as polyvinylpyrrolidone, and polyoxyethylene/polyoxypropylene copolymers of ethylene diamines. These properties represent significant advantages, relative to many of the: antimicrobial agents previously used in the ophthalmic field.
DESCRIPTION OF PREFERRED EMBODIMENTS
The compounds u
REFERENCES:
patent: 4013576 (1977-03-01), Loshaek
patent: 4185098 (1980-01-01), Cuntze et al.
patent: 4407791 (1983-10-01), Stark
patent: 4738790 (1988-04-01), Miyajima et al.
patent: 5068064 (1991-11-01), Proietta et al.
patent: 5215976 (1993-06-01), Fost et al.
patent: 5225055 (1993-07-01), Sibley et al.
patent: 5393491 (1995-02-01), Dassanayake et al.
patent: 5415837 (1995-05-01), Schafer et al.
Muzyczko, T. M., et al., "Fatty Amidoamine Derivatives: N,N-Dimethyl-N-(3-alkylamidopropyl)amines and Their Salts," Journal of the American Oil Chemists' Society, vol. 45, No. 11, pp. 720-725 (1968).
Devinsky, F., et al., "N-(dimethyl)ammino) alkyldodecanamides", Chemical Abstracts, vol. 105, No. 208483.
Limanov, V., et al., "Synthesis and bactericidal activity of quaternary (N-acylaminopropyl) ammonium salts", Chemical Abstracts, vol. 95, No. 7, pp. 28-30, Aug. 1981, abstract No. 61431.
Block, Seymour, S., "Disinfection, Sterilization and Preservation", 4th ed., p. 232 (1991).
Dassanayake Nissanke L.
Park Joonsup
Schlitzer Ronald L.
Alcon Laboratories Inc.
Arno James A.
Brown Gregg C.
Fay Zohreh
Mayo Michael C.
LandOfFree
Use of amidoamines in ophthalmic compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of amidoamines in ophthalmic compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of amidoamines in ophthalmic compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1722121